The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Intraprostatic PSA-TRICOM vaccine administration in patients with locally recurrent prostate cancer.
C. R. Heery
No relevant relationships to disclose
P. A. Pinto
No relevant relationships to disclose
J. Schlom
No relevant relationships to disclose
K. Y. Tsang
No relevant relationships to disclose
R. A. Madan
No relevant relationships to disclose
D. Poole
No relevant relationships to disclose
M. Vergati
No relevant relationships to disclose
B. Walter Rodriguez
No relevant relationships to disclose
M. Merino
No relevant relationships to disclose
J. L. Gulley
No relevant relationships to disclose